Business & Economy · 23 views
Walmart’s stock slides as U.S. sales are hit by falling drug prices
The supermarket chain reported comparable U.S. sales growth of 2.6% in its second-quarter earnings, its lowest in over six years.
Business & Economy 
Story intelligence
Coverage Single outlet Single-outlet story
Views 23 Community interest
Brief read Under 1 min brief 36 words
AI Summary
Walmart’s shares fell after the retailer disclosed that comparable U.S. sales grew 2.6% in the second quarter, marking its slowest growth in more than six years. The decline was attributed to lower drug prices affecting sales.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Business & Economy
Continue reading recent Business & Economy coverage
- My brother-in-law convinced his parents to sign over their home and life savings to buy a $3 million compound. Do I intervene?Continue reading
- S&P 500 Hits Record High Amid Rising Interest Rates and Elevated Oil PricesContinue reading
- Chart: A look at the S&P 500's remarkable and defiant trip to a new recordContinue reading
- Google makes a fresh bet on nuclear power as the AI energy crunch intensifiesContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow